ERAS Erasca, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 11, 2026
$14,74
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$2,11rendah 52m
$24,28tinggi 52m
Kapitalisasi Pasar (MRQ)
$4.61B
P/E
-33.5
EPS
$-0.44
lencana Anda
Rentang 52M
$2–$24
Peringkat Analis
BUY
Target Harga
$24
P/E
-33.5
ROE
-35.7%
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
ERAS Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$14.74
Kapitalisasi Pasar (MRQ)
$4.61B
P/E
-33.5
EPS
$-0.44
ROE
-35.7%
Rentang 52M
$2–$24
ERAS Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
EPS$-0.442021-12-31 → 2025-12-31
Arus Kas Bebas$-96M2021-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | ERAS | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -33.5rata-rata 5T ≈-5.0 | ≈-5.0 | · | · | |
| P/B (MRQ) | 12.7rata-rata 5T ≈2.3 | ≈2.3 | 5.2 | Terlalu mahal | |
| Harga / FCF (TTM) | -47.0rata-rata 5T ≈-9.3 | ≈-9.3 | · | · | |
| Harga / Arus Kas (TTM) | -47.0rata-rata 5T ≈-10.1 | ≈-10.1 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 12.9rata-rata 5T ≈2.3 | ≈2.3 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | ERAS | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| ROA | -27.7%rata-rata 5T ≈-35.6% | ≈-35.6% | -25.8% | Sejajar | |
| ROE | -35.7%rata-rata 5T ≈-39.9% | ≈-39.9% | -38.2% | Sejajar | |
| ROIC | -43.3% | · | -9.7% | Lemah |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | ERAS | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 8.3rata-rata 5T ≈11.4 | ≈11.4 | 8.9 | Likuiditas rendah | |
| Quick Ratio (Rasio Cepat) | 9.7rata-rata 5T ≈11.2 | ≈11.2 | 8.0 | Sejajar |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-34.1%
Laporan Berikutnya
Nov 10, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 10, 2026 | $-0.14 | $-0.10 | -34.7% |
| 31 Maret 2026 | Mei 11, 2026 | $-0.60 | $-0.21 | -181.6% |
| 31 Des. 2025 | $-0.10 | $-0.11 | 8.3% | |
| 30 Sep. 2025 | $-0.11 | $-0.11 | -4.4% | |
| 30 Juni 2025 | $-0.12 | $-0.11 | -7.0% | |
| 31 Maret 2025 | $-0.11 | $-0.13 | 14.4% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| SG&A Expense | $39M | $42M | $38M | $33M | $23M | $8M | |
| Operating Expenses | $141M | $180M | $142M | $247M | $125M | $109M | |
| Operating Income | $-141M | $-180M | $-142M | $-247M | $-125M | $-109M | |
| Other Non-op | $16M | $18M | $16M | $5M | $314.0K | $-102.0K | |
| Pretax Income | $-125M | $-162M | · | · | · | · | |
| Income Tax | $0 | $0 | · | · | · | · | |
| Net Income | $-125M | $-162M | $-125M | $-243M | $-123M | $-102M | |
| EPS (Basic) | $-0.44 | $-0.69 | $-0.83 | $-1.99 | $-1.85 | · | |
| EPS (Diluted) | $-0.44 | $-0.69 | $-0.83 | $-1.99 | $-1.85 | · | |
| Shares (Basic) | 283,533,696 | 233,817,916 | 150,184,994 | 122,024,848 | 66,290,592 | · | |
| Shares (Diluted) | 283,533,696 | 233,817,916 | 150,184,994 | 122,024,848 | 66,290,592 | · | |
| EBITDA | $-138M | $-176M | $-138M | $-245M | $-124M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $74M | $68M | $93M | $284M | $360M | $65M | |
| Short-term Investments | $202M | $231M | $219M | $151M | $54M | $53M | |
| Prepaid Expense | $10M | $10M | $8M | $9M | $6M | $1M | |
| Current Assets | $286M | $309M | $321M | $444M | $420M | $120M | |
| PP&E (Net) | $13M | $16M | $22M | $25M | $16M | $2M | |
| PP&E (Gross) | $26M | $26M | $30M | $28M | $18M | $3M | |
| Accum. Depreciation | $13M | $10M | $7M | $4M | $2M | $902.0K | |
| Other Non-current Assets | $1M | $3M | $4M | $5M | $3M | $451.0K | |
| Total Assets | $396M | $503M | $395M | $515M | $501M | $125M | |
| Accounts Payable | $981.0K | $468.0K | $2M | $23M | $5M | $878.0K | |
| Current Liabilities | $29M | $31M | $26M | $49M | $26M | $14M | |
| Capital Leases | $42M | $47M | $52M | $54M | $19M | $2M | |
| Other Non-current Liabilities | $399.0K | $362.0K | $566.0K | $573.0K | $158.0K | · | |
| Total Liabilities | $71M | $79M | $79M | $103M | $45M | $17M | |
| Common Stock | $28.0K | $28.0K | $15.0K | $15.0K | $12.0K | $3.0K | |
| Retained Earnings | $-892M | $-768M | $-606M | $-481M | $-238M | $-115M | |
| AOCI | $628.0K | $405.0K | $77.0K | $-1M | $-162.0K | $2.0K | |
| Stockholders' Equity | $325M | $423M | $317M | $412M | $457M | $-114M | |
| Liabilities + Equity | $396M | $503M | $395M | $515M | $501M | $125M | |
| Shares Outstanding | 284,159,076 | 283,218,344 | 151,090,227 | 149,333,258 | 119,102,505 | 21,923,173 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $3M | $4M | $4M | $3M | $829.0K | $540.0K | |
| Stock-based Comp | $25M | $27M | $26M | $20M | $8M | $797.0K | |
| Other Non-cash | $1M | $21M | $-6M | $117M | $34M | · | |
| Operating Cash Flow | $-95M | $-109M | $-101M | $-103M | $-80M | $-33M | |
| CapEx | $128.0K | $60.0K | $2M | $15M | $11M | $947.0K | |
| Investing Cash Flow | $100M | $-157M | $-91M | $-71M | $-65M | $-71M | |
| Stock Issued | · | · | · | $95M | · | · | |
| Net Stock Activity | · | · | · | $95M | · | · | |
| Financing Cash Flow | $1M | $241M | $1M | $98M | $439M | $140M | |
| Net Change in Cash | $6M | $-25M | $-191M | $-76M | $295M | $36M | |
| Free Cash Flow | $-96M | $-109M | $-103M | $-118M | $-91M | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -27.7% | -36.0% | -27.5% | -47.8% | -39.2% | · | |
| ROE | -35.7% | -37.0% | -38.1% | -62.5% | -26.1% | · | |
| ROIC | -43.3% | · | · | · | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 10.0 | 9.8 | 12.3 | 9.1 | 15.9 | · | |
| Quick Ratio | 9.7 | 9.5 | 11.9 | 8.9 | 15.7 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.14 | $1.50 | $2.10 | $2.76 | $3.83 | · | |
| Cash Flow / Share | $-0.34 | $-0.47 | $-0.67 | $-0.85 | · | · | |
| Cash / Share | $0.26 | $0.24 | $0.62 | $1.90 | $3.03 | · | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | $0.00 | · | · | |
| EPS (TTM) | $-0.44 | $-0.69 | $-0.83 | $-1.99 | $-1.85 | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-125M | $-162M | $-125M | $-243M | $-123M | · | |
| Market Cap | $1.06B | $711M | $322M | $644M | $1.86B | · | |
| P/E | -8.5 | -3.6 | -2.6 | -2.2 | -8.4 | · | |
| P/B | 3.3 | 1.7 | 1.0 | 1.6 | 4.1 | · | |
| P / Tangible Book | 3.3 | 1.7 | 1.0 | 1.6 | 4.1 | · | |
| P / Cash Flow | -11.1 | -6.5 | -3.2 | -6.2 | -23.3 | · | |
| P / FCF | -11.1 | -6.5 | -3.1 | -5.5 | -20.4 | · | |
| Earnings Yield | -11.8% | -27.5% | -39.0% | -46.2% | -11.9% | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SG&A Expense | $12M | $11M | $9M | $10M | $9M | $10M | $10M | $10M | $12M | $10M | $9M | $9M | $10M | $9M | $9M | $9M | |
| Operating Expenses | $48M | $188M | $33M | $35M | $38M | $36M | $36M | $37M | $68M | $39M | $34M | $35M | $36M | $37M | $138M | $37M | |
| Operating Income | $-48M | $-188M | $-33M | $-35M | $-38M | $-36M | $-36M | $-37M | $-68M | $-39M | $-34M | $-35M | $-36M | $-37M | $-138M | $-37M | |
| Other Non-op | $4M | $22.0K | $7M | $-37.0K | $4M | $-76.0K | $9M | $173.0K | $5M | $4M | $9M | $-49.0K | $4M | $4M | $3M | $1M | |
| Net Income | $-44M | $-183M | $-29M | $-31M | $-34M | $-31M | $-32M | $-31M | $-63M | $-35M | $-30M | $-30M | $-32M | $-33M | $-135M | $-35M | |
| EPS (Basic) | $-0.14 | $-0.60 | $-0.10 | $-0.11 | $-0.12 | $-0.11 | $-0.06 | $-0.11 | $-0.29 | $-0.23 | $-0.20 | $-0.20 | $-0.21 | $-0.22 | $-1.09 | $-0.29 | |
| EPS (Diluted) | $-0.14 | $-0.60 | $-0.10 | $-0.11 | $-0.12 | $-0.11 | $-0.06 | $-0.11 | $-0.29 | $-0.23 | $-0.20 | $-0.20 | $-0.21 | $-0.22 | $-1.09 | $-0.29 | |
| Shares (Basic) | 311,336,806 | 304,317,460 | · | 283,681,570 | 283,355,730 | 283,260,289 | · | 282,384,964 | 217,806,567 | 151,161,741 | · | 150,450,201 | 150,037,029 | 149,504,216 | · | 120,798,322 | |
| Shares (Diluted) | 311,336,806 | 304,317,460 | · | 283,681,570 | 283,355,730 | 283,260,289 | · | 282,384,964 | 217,806,567 | 151,161,741 | · | 150,450,201 | 150,037,029 | 149,504,216 | · | 120,798,322 | |
| EBITDA | $-47M | $-187M | · | $-34M | $-37M | $-35M | · | $-36M | $-67M | $-38M | · | $-34M | $-35M | $-36M | · | $-36M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $47M | $74M | $70M | $66M | $70M | $68M | $69M | $173M | $77M | $93M | $113M | $139M | $273M | $284M | $219M | |
| Short-term Investments | $226M | $197M | $202M | $218M | $235M | $234M | $231M | $250M | $236M | $221M | $219M | $184M | $178M | $117M | $151M | $137M | |
| Prepaid Expense | $10M | $10M | $10M | $12M | $10M | $10M | $10M | $11M | $10M | $9M | $8M | $9M | $7M | $8M | $9M | $10M | |
| Current Assets | $278M | $254M | $286M | $300M | $311M | $315M | $309M | $330M | $418M | $307M | $321M | $306M | $324M | $398M | $444M | $366M | |
| PP&E (Net) | $12M | $13M | $13M | $14M | $15M | $16M | $16M | $17M | $18M | $21M | $22M | $23M | $24M | $25M | $25M | $25M | |
| PP&E (Gross) | $26M | $26M | $26M | $26M | $26M | $26M | $26M | $26M | $26M | $30M | $30M | $30M | $29M | $29M | $28M | $27M | |
| Accum. Depreciation | $14M | $13M | $13M | $12M | $11M | $11M | $10M | $9M | $8M | $8M | $7M | $6M | $5M | $4M | $4M | $3M | |
| Other Non-current Assets | $1M | $1M | $1M | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | |
| Total Assets | $435M | $461M | $396M | $420M | $445M | $471M | $503M | $529M | $526M | $370M | $395M | $419M | $441M | $468M | $515M | $446M | |
| Accounts Payable | $2M | $2M | $981.0K | $3M | $2M | $2M | $468.0K | $2M | $2M | $3M | $2M | $4M | $3M | $3M | $23M | $4M | |
| Current Liabilities | $34M | $27M | $29M | $29M | $28M | $25M | $31M | $30M | $25M | $30M | $26M | $27M | $23M | $26M | $49M | $28M | |
| Capital Leases | $39M | $41M | $42M | $43M | $45M | $46M | $47M | $48M | $50M | $51M | $52M | $53M | $54M | $55M | $54M | $53M | |
| Other Non-current Liabilities | $341.0K | $340.0K | $399.0K | $395.0K | $263.0K | $251.0K | $362.0K | $340.0K | $82.0K | $559.0K | $566.0K | $761.0K | $697.0K | $630.0K | $573.0K | · | |
| Total Liabilities | $73M | $68M | $71M | $73M | $73M | $72M | $79M | $79M | $75M | $82M | $79M | $80M | $78M | $81M | $103M | $81M | |
| Common Stock | $31.0K | $31.0K | $28.0K | $28.0K | $28.0K | $28.0K | $28.0K | $28.0K | $27.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | $12.0K | |
| Retained Earnings | $-1.12B | $-1.08B | $-892M | $-863M | $-833M | $-799M | $-768M | $-735M | $-704M | $-641M | $-606M | $-576M | $-546M | $-514M | $-481M | $-346M | |
| AOCI | $-1M | $-699.0K | $628.0K | $649.0K | $415.0K | $628.0K | $405.0K | $2M | $-196.0K | $-210.0K | $77.0K | $-575.0K | $-793.0K | $-514.0K | $-1M | $-1M | |
| Stockholders' Equity | $362M | $394M | $325M | $348M | $372M | $400M | $423M | $450M | $451M | $288M | $317M | $339M | $363M | $386M | $412M | $365M | |
| Liabilities + Equity | $435M | $461M | $396M | $420M | $445M | $471M | $503M | $529M | $526M | $370M | $395M | $419M | $441M | $468M | $515M | $446M | |
| Shares Outstanding | 312,556,206 | 310,806,888 | 284,159,076 | 283,711,805 | 283,650,139 | 283,265,716 | 283,218,344 | 282,690,975 | 273,039,997 | 151,249,219 | 151,090,227 | 150,537,752 | 150,383,261 | 149,699,528 | 149,333,258 | 121,024,938 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $716.0K | $723.0K | $743.0K | $755.0K | $787.0K | $822.0K | $865.0K | $842.0K | $1M | $998.0K | $942.0K | $941.0K | $955.0K | $894.0K | $933.0K | $771.0K | |
| Stock-based Comp | $10M | $8M | $6M | $6M | $6M | $7M | $6M | $7M | $7M | $7M | $6M | $6M | $7M | $7M | $5M | $5M | |
| Other Non-cash | · | $147M | · | · | · | $-8M | · | · | · | $-6M | · | · | · | $-898.0K | · | · | |
| Operating Cash Flow | $-27M | $-27M | $-22M | $-22M | $-21M | $-32M | $-25M | $-22M | $-29M | $-33M | $-25M | $-24M | $-26M | $-26M | $-26M | $-24M | |
| CapEx | $8.0K | $36.0K | $9.0K | $6.0K | $30.0K | $83.0K | $0 | $5.0K | $13.0K | $42.0K | $82.0K | $240.0K | $247.0K | $1M | $864.0K | $2M | |
| Investing Cash Flow | $19M | $-244M | $25M | $26M | $16M | $34M | $23M | $-103M | $-87M | $10M | $5M | $-2M | $-109M | $15M | $-5M | $-55M | |
| Stock Issued | $0 | $259M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $259M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $3M | $245M | $575.0K | $41.0K | $447.0K | $33.0K | $801.0K | $21M | $212M | $7M | $456.0K | $7.0K | $649.0K | $183.0K | $96M | $427.0K | |
| Net Change in Cash | $-5M | $-27M | $4M | $4M | $-4M | $3M | $-1M | $-104M | $96M | $-16M | $-20M | $-26M | $-134M | $-11M | $65M | $-79M | |
| Free Cash Flow | · | $-27M | · | · | · | $-32M | · | · | · | $-33M | · | · | · | $-28M | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.0% | -39.3% | · | -6.5% | -7.0% | -7.4% | · | -6.6% | -13.1% | -8.4% | · | -7.0% | -7.2% | -7.0% | · | -7.3% | |
| ROE | -12.0% | -46.3% | · | -7.7% | -8.2% | -9.0% | · | -7.9% | -15.5% | -10.4% | · | -8.6% | -8.4% | -8.2% | · | -8.4% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.3 | 9.5 | · | 10.4 | 11.0 | 12.4 | · | 11.0 | 16.8 | 10.1 | · | 11.4 | 13.9 | 15.6 | · | 13.2 | |
| Quick Ratio | 8.0 | 9.1 | · | 10.0 | 10.7 | 12.0 | · | 10.6 | 16.4 | 9.8 | · | 11.1 | 13.6 | 15.3 | · | 12.9 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.16 | $1.27 | · | $1.23 | $1.31 | $1.41 | · | $1.59 | $1.65 | $1.91 | · | $2.25 | $2.41 | $2.58 | · | $3.02 | |
| Cash Flow / Share | · | $-0.09 | · | · | · | $-0.11 | · | · | · | $-0.22 | · | · | · | $-0.18 | · | · | |
| Cash / Share | $0.14 | $0.15 | · | $0.25 | $0.23 | $0.25 | · | $0.24 | $0.63 | $0.51 | · | $0.75 | $0.92 | $1.82 | · | $1.81 | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | $0.00 | · | · | · | · | · | · | · | · | · | · | · | · | |
| EPS (TTM) | $-0.95 | $-0.93 | · | $-0.40 | $-0.40 | $-0.57 | · | $-0.83 | $-0.92 | $-0.84 | · | $-1.72 | $-1.81 | $-1.90 | · | $-0.85 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-287M | $-277M | · | $-128M | $-128M | $-158M | · | $-159M | $-158M | $-127M | · | $-231M | $-236M | $-240M | · | $-138M | |
| Market Cap | $5.73B | $5.03B | · | $618M | $360M | $388M | · | $772M | $644M | $312M | · | $297M | $415M | $451M | · | $944M | |
| P/E | -19.3 | -17.4 | · | -5.5 | -3.2 | -2.4 | · | -3.3 | -2.6 | -2.5 | · | -1.1 | -1.5 | -1.6 | · | -9.2 | |
| P/B | 15.8 | 12.8 | · | 1.8 | 1.0 | 1.0 | · | 1.7 | 1.4 | 1.1 | · | 0.9 | 1.1 | 1.2 | · | 2.6 | |
| P / Tangible Book | 15.8 | 12.8 | · | 1.8 | 1.0 | 1.0 | · | 1.7 | 1.4 | 1.1 | · | 0.9 | 1.1 | 1.2 | · | 2.6 | |
| P / Cash Flow | · | -183.6 | · | · | · | -12.3 | · | · | · | -9.4 | · | · | · | -17.1 | · | · | |
| Earnings Yield | -5.2% | -5.8% | · | -18.4% | -31.5% | -41.6% | · | -30.4% | -39.0% | -40.8% | · | -87.3% | -65.6% | -63.1% | · | -10.9% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Laba Bersih | $-125M | $-162M | $-125M | $-243M | $-123M |
| EPS Dilusian | $-0.44 | $-0.69 | $-0.83 | $-1.99 | $-1.85 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 10.0 | 9.8 | 12.3 | 9.1 | 15.9 |
| Rasio Cepat | 9.7 | 9.5 | 11.9 | 8.9 | 15.7 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-96M | $-109M | $-103M | $-118M | $-91M |
Pemilik institusional (13F) 274 pengaju · $4.9B total · Per tanggal 30 Sep. 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
274
Nilai yang dipegang
$4.9B
Posisi baru
66
Posisi yang keluar
26
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 66 (-31 vs Kuartal sebelumnya) | 26 (+5 vs Kuartal sebelumnya) | 108 (+28 vs Kuartal sebelumnya) | 75 (+36 vs Kuartal sebelumnya) | +14.2M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | $457.545.444 | 24.975.188 | 9,38% | Saham |
| BlackRock, Inc. | $387.543.955 | 21.154.146 | 7,94% | Saham |
| RTW INVESTMENTS, LP | $328.784.533 | 17.946.754 | 6,74% | Saham |
| Venrock Adviser, LLC | $327.777.996 | 17.891.812 | 6,72% | Saham |
| STATE STREET CORP | $223.221.048 | 12.184.555 | 4,58% | Saham |
| Logos Global Management LP | $222.588.000 | 12.150.000 | 4,56% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $208.888.286 | 11.402.199 | 4,28% | Saham |
| Siren, L.L.C. | $208.807.348 | 11.397.781 | 4,28% | Saham |
| Paradigm Biocapital Advisors LP | $174.956.000 | 9.550.000 | 3,59% | Saham |
| ARCH Venture Management, LLC | $129.917.324 | 7.091.557 | 2,66% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $119.128.739 | 6.501.426 | 2,44% | Saham |
| Cormorant Asset Management, LP | $109.920.000 | 6.000.000 | 2,25% | Saham |
| Affinity Asset Advisors, LLC | $96.180.000 | 5.250.000 | 1,97% | Saham |
| Vivo Capital, LLC | $75.614.188 | 4.127.412 | 1,55% | Saham |
| GOLDMAN SACHS GROUP INC | $70.021.110 | 3.822.113 | 1,44% | Saham |
| Caption Management, LLC | $68.535.120 | 3.741.000 | 1,40% | Opsi beli |
| ALLIANCEBERNSTEIN L.P. | $66.639.175 | 4.118.614 | 1,37% | Saham |
| JANUS HENDERSON GROUP PLC | $59.987.765 | 3.710.966 | 1,23% | Saham |
| BANK OF AMERICA CORP /DE/ | $55.852.862 | 3.048.737 | 1,14% | Saham |
| FMR LLC | $52.824.202 | 2.883.417 | 1,08% | Saham |
| a16z Capital Management, L.L.C. | $52.441.000 | 2.862.500 | 1,07% | Saham |
| Woodline Partners LP | $51.879.803 | 2.831.867 | 1,06% | Saham |
| JENNISON ASSOCIATES LLC | $51.083.708 | 2.788.412 | 1,05% | Saham |
| Soleus Capital Management, L.P. | $49.464.000 | 2.700.000 | 1,01% | Saham |
| VANGUARD GROUP INC | $47.661.220 | 12.812.156 | 0,98% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $43.782.308 | 2.389.864 | 0,90% | Saham |
| SAMLYN CAPITAL, LLC | $41.347.983 | 2.256.986 | 0,85% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $37.410.063 | 2.042.034 | 0,77% | Saham |
| NORTHERN TRUST CORP | $35.872.759 | 1.958.120 | 0,74% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $35.628.553 | 1.944.790 | 0,73% | Saham |
| VICTORY CAPITAL MANAGEMENT INC | $35.475.984 | 1.936.462 | 0,73% | Saham |
| Nuveen, LLC | $33.740.585 | 1.841.735 | 0,69% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $32.315.360 | 1.763.980 | 0,66% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $31.107.195 | 1.697.991 | 0,64% | Saham |
| UBS Group AG | $29.250.848 | 1.596.662 | 0,60% | Saham |
| STEMPOINT CAPITAL LP | $28.687.526 | 1.565.913 | 0,59% | Saham |
| Rock Springs Capital Management LP | $25.687.388 | 1.402.150 | 0,53% | Saham |
| Evergreen Quality Fund GP, Ltd. | $25.195.496 | 1.375.300 | 0,52% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $25.078.578 | 1.368.918 | 0,51% | Saham |
| FRED ALGER MANAGEMENT, LLC | $23.970.896 | 1.308.455 | 0,49% | Saham |
| SILVERARC CAPITAL MANAGEMENT, LLC | $23.138.636 | 1.263.026 | 0,47% | Saham |
| Point72 Asset Management, L.P. | $22.848.759 | 1.247.203 | 0,47% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $22.780.920 | 1.243.500 | 0,47% | Opsi beli |
| First Turn Management, LLC | $22.381.929 | 1.221.721 | 0,46% | Saham |
| FEDERATED HERMES, INC. | $19.827.040 | 1.082.262 | 0,41% | Saham |
| Caption Management, LLC | $19.075.242 | 1.041.225 | 0,39% | Saham |
| Integral Health Asset Management, LLC | $18.320.000 | 1.000.000 | 0,38% | Saham |
| D. E. Shaw & Co., Inc. | $17.396.489 | 949.590 | 0,36% | Saham |
| MILLENNIUM MANAGEMENT LLC | $16.667.792 | 909.814 | 0,34% | Saham |
| Invesco Ltd. | $15.838.135 | 864.527 | 0,32% | Saham |
Aktivis & pemilik 5%+ 1 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Asset Management, LP, Bihua Chen ×4 pengajuan | 30 Jan. 2024 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 14 orang dalam · 5 pejabat · 9 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Jonathan E Lim | Chairman & CEO | 29 Jan. 2026 A | 12.899.360 | 0 | 0 | $0 |
| David M. Chacko | CFO and CBO | 29 Jan. 2026 A | 279.980 | 0 | 0 | $0 |
| Ebun Garner | Chief Legal Officer | 1 April 2026 M | 25.076 | 0 | 2 | $-1.982.800 |
| Shannon Morris | Chief Medical Officer | 4 Maret 2025 M | 0 | 0 | 1 | $-300.800 |
| Lin Wei | Chief Medical Officer | 1 Feb. 2023 A | 315.812 | 0 | 0 | $0 |
| James Arthur Bristol | Direktur | 26 Juni 2026 A | 20.000 | 0 | 0 | $0 |
| Valerie Denise Harding Start | Direktur | 26 Juni 2026 A | 20.000 | 0 | 0 | $0 |
| Pratik S Multani | Direktur | 26 Juni 2026 A | 6.200 | 0 | 0 | $0 |
| Julie Hambleton | Direktur | 26 Juni 2026 A | 6.000 | 0 | 0 | $0 |
| Alexander W. Casdin | Direktur | 26 Juni 2026 A | 573.974 | 0 | 0 | $0 |
| Jean I Liu | Direktur | 26 Juni 2026 A | · | 0 | 0 | $0 |
| Michael David Varney | Direktur | 29 Jan. 2026 A | · | 0 | 0 | $0 |
| Chen Bihua | Direktur | 22 Juni 2022 A | 10.505.553 | 0 | 0 | $0 |
| Charles S. Fuchs | · | 10 Agu 2026 A | · | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 35 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 2,26% | 567.358 SH | 1 Okt. 2026 | Harian |
| DWAS · Invesco Exchange-Traded Fund Trust … | 1,42% | 395.404 SH | 1 Okt. 2026 | Harian |
| LABU · Direxion Shares ETF Trust | 0,93% | 252.386 NS | 31 Juli 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,87% | 22.122 NS | 31 Juli 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0,39% | 1.956 NS | 31 Juli 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,34% | 24.747 SH | 1 Okt. 2026 | Harian |
| IBB · iShares Trust | 0,29% | 1.881.079 SH | 11 Sep. 2026 | Harian |
| ESSC · Strategy Shares | 0,28% | 5.493 NS | 31 Juli 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,26% | 3.448 NS | 31 Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,23% | 2.068.727 SH | 11 Sep. 2026 | Harian |
| VFMO · VANGUARD WELLINGTON FUND | 0,22% | 244.429 SH | 19 Agu 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,22% | 214.594 SH | 19 Agu 2026 | Harian |
| BKSE · BNY Mellon ETF Trust | 0,17% | 8.052 NS | 31 Juli 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,15% | 59.277 NS | 31 Juli 2026 | N-PORT |
| RSSL · Global X Funds | 0,13% | 105.514 NS | 31 Juli 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,12% | 21.102 SH | 1 Okt. 2026 | Harian |
| IWM · iShares Trust | 0,12% | 5.643.821 SH | 11 Sep. 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,11% | 1.151.944 SH | 19 Agu 2026 | Harian |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,05% | 100.557 SH | 1 Okt. 2026 | Harian |
| VXF · VANGUARD INDEX FUNDS | 0,05% | 2.745.733 SH | 19 Agu 2026 | Harian |
| FHLC · FIDELITY COVINGTON TRUST | 0,05% | 85.467 NS | 31 Juli 2026 | N-PORT |
| ESML · iShares Trust | 0,05% | 81.147 SH | 11 Sep. 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,04% | 467.663 SH | 19 Agu 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,03% | 263.455 NS | 31 Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,03% | 10.485 SH | 11 Sep. 2026 | Harian |
| DFAC · Dimensional ETF Trust | 0,02% | 402.637 NS | 31 Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 8.386.105 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 16.688 SH | 19 Agu 2026 | Harian |
| ITOT · iShares Trust | 0,01% | 334.866 SH | 11 Sep. 2026 | Harian |
| IWV · iShares Trust | 0,00% | 59.143 SH | 11 Sep. 2026 | Harian |
| DFUS · Dimensional ETF Trust | 0,00% | 33.981 NS | 31 Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 18.981 NS | 31 Juli 2026 | N-PORT |
| ISCB · iShares Trust | · | 9.786 SH | 11 Sep. 2026 | Harian |
| ISCV · iShares Trust | · | 48.754 SH | 11 Sep. 2026 | Harian |
| SMLF · iShares Trust | · | 239.252 SH | 11 Sep. 2026 | Harian |
ERAS Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 17 analis
BELI
Target median
$22.00
+49,3%
5 29,4%
Beli Kuat
9 52,9%
Beli
3 17,6%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
9 analis · 2026-09-27Target rata-rata $24.11 +63,6%
← Di bawah semua target
Harga saat ini $14.74
Rendah$20.00
Rata-rata$24.11
Tinggi$33.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| ERAS | $1.06B | -8.5 | · | · | -35.7% | · |
| COGT | $5.72B | -16.4 | · | · | -83.1% | · |
| MIRM | $4.10B | -168.1 | 54.7% | -4.5% | -8.2% | · |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | · |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | · |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | · |
| RLAY | $1.47B | -5.3 | 53.4% | -1800.6% | -44.9% | · |
| TNGX | $1.20B | -10.2 | 48.3% | -162.8% | -42.2% | · |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Here is Why Erasca (ERAS) is One of the Best Growth Stocks Under $20
Yahoo Finance · 3 bulan, 4 minggu lalu
Mengapa Dana Ini Membuat Taruhan $189 Juta pada Erasca saat Saham Melonjak 800%
Nasdaq · 4 bulan lalu
Acuta Capital Bertaruh pada Erasca (ERAS) dan Menargetkan Pengobatan Kanker dengan Pembelian 354.575 Saham
Nasdaq · 4 bulan, 2 minggu lalu
JPMorgan Merekomendasikan Pembelian Saham Erasca (ERAS) pada Level Saat Ini
Yahoo Finance · 4 bulan, 3 minggu lalu
Erasca (ERAS) Naik 390% YTD Berkat Potensi Pengobatan Kanker 'Terbaik di Kelasnya'
Yahoo Finance · 5 bulan, 2 minggu lalu
Apa yang Mendorong Pengembalian Erasca (ERAS) Hampir 355% YTD
Yahoo Finance · 5 bulan, 3 minggu lalu
Erasca (ERAS) Tambah 13%; Melonjak 310% YTD
Yahoo Finance · 6 bulan, 1 minggu lalu
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 11, 2026